Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 2008; 100(03): 367-368
DOI: 10.1160/TH08-08-0517
DOI: 10.1160/TH08-08-0517
Editorial Focus
Improving clinical outcomes for patients with cancer-associated thrombosis
Further Information
Publication History
Received
11 August 2008
Accepted
11 August 2008
Publication Date:
22 November 2017 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/200803/lookinside/thumbnails/10-1160-th08-08-517-1.jpg)
-
References
- 1 Prandoni P, Lensing AW, Piccioli A. et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002; 100: 3484-3488.
- 2 Levine MN. Can we optimise treatment of thrombosis?. Cancer Treat Rev 2003; 29 (Suppl. 02) 19-22.
- 3 Lyman GH, Khorana AA, Falanga A. et al. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 2007; 25: 5490-5505.
- 4 Trujillo-Santos J, Nieto JA, Antonio J. et al. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry. Thromb Haemost 2008; 100: 435-439.
- 5 Khorana A, Kuderer MN, Culakova E. et al. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 2008; 111: 4902-4907.
- 6 Zwicker JL. Tissue factor-bearing microparticles and cancer. Semin Thromb Hemost 2008; 34: 195-198.